UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 10-Q
 
(Mark one)
ýQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 201830, 2019
 
Or 

oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from            to            
 
Commission file number: 000-50307
 
FormFactor, Inc.
(Exact name of registrant as specified in its charter)
Delaware 13-3711155
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
 
7005 Southfront Road, Livermore, California 94551
(Address of principal executive offices, including zip code)
 
(925) 290-4000
(Registrant’s telephone number, including area code)
 


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes ý  No o
 
Indicate by check mark whether the registrant submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of the Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes ý  No o
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
Large Accelerated filer x
 
Accelerated filer o
   
Non-accelerated filer o
 
Smaller reporting company o
(Do not check if a smaller reporting company)  
Emerging growth company o
  
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  o   

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes o  No ý 

As of May 3, 2018, 73,031,8641, 2019, 74,581,339 shares of the registrant’s common stock, par value $0.001$0.001 per share, were outstanding.
 

FORMFACTOR, INC.
FORM 10-Q FOR THE QUARTERLY PERIOD ENDED MARCH 31, 201830, 2019
INDEX

 
   
 
   
 
   
 
   
 
   
 
   
 
   
   
   
   
   
   
   
 



PART I - FINANCIAL INFORMATION
 
Item 1. Financial Statements
 
FORMFACTOR, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share amounts)
(Unaudited)
FORMFACTOR, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share amounts)
(Unaudited)
FORMFACTOR, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share amounts)
(Unaudited)
March 31,
2018
 December 30, 2017March 30,
2019
 December 29, 2018
ASSETS 
  
 
 

Current assets: 
  
 
  
Cash and cash equivalents$93,699
 $91,184
$105,759
 $98,472
Marketable securities48,370
 48,988
54,086
 50,531
Accounts receivable, net of allowance for doubtful accounts of $200 and $20078,524
 81,515
Accounts receivable, net of allowance for doubtful accounts of $185 and $18581,492
 95,333
Inventories, net73,780
 67,848
83,216
 77,706
Restricted cash663
 372
824
 849
Refundable income taxes2,307
 2,242
1,261
 1,260
Prepaid expenses and other current assets14,452
 13,705
11,747
 13,669
Total current assets311,795
 305,854
338,385
 337,820
Restricted cash1,020
 1,170
1,130
 1,225
Property, plant and equipment, net of accumulated depreciation and amortization of $259,608 and $255,75547,851
 46,754
Operating lease, right-of-use-assets34,397
 
Property, plant and equipment, net of accumulated depreciation of $266,274 and $263,10254,697
 54,054
Goodwill190,367
 189,920
188,925
 189,214
Intangibles, net90,649
 97,484
60,385
 67,640
Deferred tax assets3,145
 3,133
77,293
 77,301
Other assets1,361
 2,259
1,409
 968
Total assets$646,188
 $646,574
$756,621
 $728,222
   
LIABILITIES AND STOCKHOLDERS’ EQUITY 
 

 
  
Current liabilities: 
 

 
  
Accounts payable$38,889
 $35,046
$31,555
 $40,006
Accrued liabilities23,496
 33,694
22,559
 27,731
Current portion of term loan, net of unamortized issuance cost of $270 and $30729,730
 18,443
Current portion of term loan, net of unamortized issuance cost of $128 and $16033,622
 29,840
Deferred revenue4,515
 4,978
6,885
 4,941
Operating lease liabilities6,022
 
Total current liabilities96,630
 92,161
100,643
 102,518
Term loan, less current portion, net of unamortized issuance cost of $185 and $27267,315
 87,228
Term loan, less current portion, net of unamortized issuance cost of $10 and $2923,740
 34,971
Deferred tax liabilities3,487
 3,379
2,306
 2,355
Deferred rent and other liabilities7,746
 5,169
Long-term operating lease liabilities32,239
 
Other liabilities4,705
 8,214
Total liabilities175,178
 187,937
163,633
 148,058



 

 
  
Stockholders’ equity: 
   
  
Preferred stock, $0.001 par value: 
   
  
10,000,000 shares authorized; no shares issued and outstanding
 

 
Common stock, $0.001 par value: 
 

 
  
250,000,000 shares authorized; 73,013,842 and 72,532,176 shares issued and outstanding74
 73
250,000,000 shares authorized; 74,488,498 and 74,139,712 shares issued and outstanding74
 74
Additional paid-in capital851,249
 843,116
871,617
 862,897
Accumulated other comprehensive income5,185
 3,021
Accumulated other comprehensive income (loss)(599) 780
Accumulated deficit(385,498) (387,573)(278,104) (283,587)
Total stockholders’ equity471,010
 458,637
592,988
 580,164
Total liabilities and stockholders’ equity$646,188
 $646,574
$756,621
 $728,222
 
The accompanying notes are an integral part of these condensed consolidated financial statements. 


FORMFACTOR, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share amounts)
(Unaudited)
FORMFACTOR, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share amounts)
(Unaudited)
FORMFACTOR, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share amounts)
(Unaudited)
Three Months EndedThree Months Ended
March 31,
2018
 April 1,
2017
March 30,
2019
 March 31,
2018
Revenues$118,290
 $128,829
$132,213
 $118,290
Cost of revenues73,161
 81,258
79,692
 73,161
Gross profit45,129
 47,571
52,521
 45,129
Operating expenses: 
  
 
  
Research and development18,046
 17,414
19,723
 18,046
Selling, general and administrative23,449
 22,829
25,184
 23,449
Restructuring and impairment charges
 269
Total operating expenses41,495
 40,512
44,907
 41,495
Operating income3,634
 7,059
7,614
 3,634
Interest income257
 67
580
 257
Interest expense(967) (1,174)(595) (967)
Other expense, net(512) (400)(84) (512)
Income before income taxes2,412
 5,552
7,515
 2,412
Provision for income taxes287
 367
2,032
 287
Net income$2,125
 $5,185
$5,483
 $2,125
Net income per share:   
   
Basic$0.03
 $0.07
$0.07
 $0.03
Diluted$0.03
 $0.07
$0.07
 $0.03
Weighted-average number of shares used in per share calculations:   
   
Basic72,826
 71,423
74,362
 72,826
Diluted74,342
 72,922
76,009
 74,342
 
The accompanying notes are an integral part of these condensed consolidated financial statements.


FORMFACTOR, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(In thousands)
(Unaudited)
 Three Months Ended
 March 31,
2018
 April 1,
2017
Net income$2,125
 $5,185
Other comprehensive income, net of tax:   
Foreign currency translation adjustments2,166
 1,447
Unrealized losses on available-for-sale marketable securities(174) 
Unrealized gains on derivative instruments172
 157
Other comprehensive income, net of tax2,164
 1,604
Comprehensive income$4,289
 $6,789
FORMFACTOR, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(In thousands)
(Unaudited)
 Three Months Ended
 March 30,
2019
 March 31,
2018
Net income$5,483
 $2,125
Other comprehensive income (loss), net of tax:   
Translation adjustments and other(917) 2,166
Unrealized gains (losses) on available-for-sale marketable securities151
 (174)
Unrealized gains (losses) on derivative instruments(613) 172
Other comprehensive income (loss), net of tax(1,379) 2,164
Comprehensive income$4,104
 $4,289

The accompanying notes are an integral part of these condensed consolidated financial statements.



FORMFACTOR, INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(In thousands)
(Unaudited)
FORMFACTOR, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
 Three Months Ended
 March 31,
2018
 April 1,
2017
Cash flows from operating activities: 
  
Net income$2,125
 $5,185
Adjustments to reconcile net income to net cash provided by operating activities: 
  
Depreciation3,525
 3,162
Amortization7,194
 8,349
Accretion of discount on investments23
 
Stock-based compensation expense3,756
 3,302
Amortization of debt issuance costs123
 171
Deferred income tax provision59
 81
Provision for excess and obsolete inventories2,045
 2,797
Acquired inventory step-up amortization
 190
Loss on disposal of long-lived assets15
 22
Gain on derivative instruments
 (65)
Foreign currency transaction gains(561) (729)
Changes in assets and liabilities: 
  
Accounts receivable3,354
 (8,888)
Inventories(7,408) (3,345)
Prepaid expenses and other current assets(247) 3,068
Refundable income taxes(52) 286
Other assets662
 615
Accounts payable2,988
 7,220
Accrued liabilities(9,521) (4,780)
Income tax payable(829) (419)
Deferred rent and other liabilities2,515
 71
Deferred revenues(444) 1,510
Net Cash provided by operating activities9,322
 17,803
Cash flows from investing activities: 
  
Acquisition of property, plant and equipment(3,831) (3,465)
Proceeds from sale of a subsidiary20
 14
Purchases of marketable securities(3,587) 
Proceeds from maturities of marketable securities4,007
 
Net cash used in investing activities(3,391) (3,451)
Cash flows from financing activities: 
  
Proceeds from issuances of common stock4,754
 7,437
Purchase and retirement of common stock
 (2,733)
Tax withholdings related to net share settlements of equity awards(357) (480)
Principal repayments on term loan(8,750) (6,875)
Net cash used in financing activities(4,353) (2,651)
Effect of exchange rate changes on cash, cash equivalents and restricted cash1,078
 1,260
Net increase in cash, cash equivalents and restricted cash2,656
 12,961
Cash, cash equivalents and restricted cash, beginning of period92,726
 102,596
Cash, cash equivalents and restricted cash, end of period$95,382
 $115,557
    
    
Non-cash investing and financing activities: 
  
Change in accounts payable and accrued liabilities related to property, plant and equipment purchases$601
 $2,035
    
Supplemental disclosure of cash flow information:   
Cash paid for income taxes, net$771
 $338
Cash paid for interest$826
 $1,016
 Shares Common Stock Additional Paid-in Capital Accumulated Other Comprehensive Income Accumulated Deficit Total
 Three Months Ended March 30, 2019
Balances, December 29, 201874,139,712
 $74
 $862,897
 $780
 $(283,587) $580,164
Issuance of common stock under the Employee Stock Purchase Plan301,497
 
 3,670
 
 
 3,670
Issuance of common stock pursuant to exercise of options for cash19,207
 
 90
 
 
 90
Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax28,082
 
 (302) 
 
 (302)
Stock-based compensation
 
 5,262
 
 
 5,262
Other comprehensive loss
 
 
 (1,379) 
 (1,379)
Net income
 
 
 
 5,483
 5,483
Balances, March 30, 201974,488,498
 $74
 $871,617
 $(599) $(278,104) $592,988
 Three Months Ended March 31, 2018
Balances, December 30, 201772,532,176
 $73
 $843,116
 $3,021
 $(387,573) $458,637
Issuance of common stock under the Employee Stock Purchase Plan341,670
 1
 3,704
 
 
 3,705
Issuance of common stock pursuant to exercise of options for cash105,610
 
 1,049
 
 
 1,049
Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax34,386
 
 (357) 
 
 (357)
Stock-based compensation
 
 3,737
 
 
 3,737
Adoption of ASU 2017-12
 
 
 
 (50) (50)
Other comprehensive income
 
 
 2,164
 
 2,164
Net income
 
 
 
 2,125
 2,125
Balances, March 31, 201873,013,842
 $74
 $851,249
 $5,185
 $(385,498) $471,010

The accompanying notes are an integral part of these condensed consolidated financial statements.


FORMFACTOR, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
 Three Months Ended
 March 30, 2019 March 31, 2018
Cash flows from operating activities: 
  
Net income$5,483
 $2,125
Adjustments to reconcile net income to net cash provided by operating activities:   
Depreciation3,947
 3,525
Amortization7,090
 7,194
Amortization (accretion) of discount on investments(71) 23
Amortization of operating lease, right-of-use assets1,277
 
Stock-based compensation expense5,295
 3,756
Amortization of debt issuance costs51
 123
Deferred income tax provision
 59
Provision for excess and obsolete inventories2,725
 2,045
Loss on disposal of long-lived assets118
 15
Loss on derivative instruments59
 
Foreign currency transaction losses (gains)121
 (561)
Changes in assets and liabilities:   
Accounts receivable13,805
 3,354
Inventories(8,658) (7,408)
Prepaid expenses and other current assets2,167
 (247)
Refundable income taxes(1) (52)
Other assets(564) 662
Accounts payable(7,148) 2,988
Accrued liabilities(6,275) (9,521)
Income tax payable943
 (829)
Other liabilities33
 2,515
Deferred revenues1,931
 (444)
Operating lease liabilities(1,690) 
Net cash provided by operating activities20,638
 9,322
Cash flows from investing activities: 
  
Acquisition of property, plant and equipment(6,028) (3,831)
Proceeds from sale of a subsidiary28
 20
Purchases of marketable securities(12,382) (3,587)
Proceeds from maturities of marketable securities9,050
 4,007
Net cash used in investing activities(9,332) (3,391)
Cash flows from financing activities: 
  
Proceeds from issuances of common stock3,870
 4,754
Tax withholdings related to net share settlements of equity awards(302) (357)
Principal repayments on term loan(7,500) (8,750)
Net cash used in financing activities(3,932) (4,353)
Effect of exchange rate changes on cash, cash equivalents and restricted cash(207) 1,078
Net increase in cash, cash equivalents and restricted cash7,167
 2,656
Cash, cash equivalents and restricted cash, beginning of period100,546
 92,726
Cash, cash equivalents and restricted cash, end of period$107,713
 $95,382
Non-cash investing and financing activities: 
  
Change in accounts payable and accrued liabilities related to property, plant and equipment purchases$(1,253) $601
Operating lease, right-of-use assets obtained in exchange for lease obligations35,713
 
Supplemental disclosure of cash flow information:   
Cash paid for income taxes, net$1,082
 $771
Cash paid for interest302
 826
The accompanying notes are an integral part of these condensed consolidated financial statements.


FORMFACTOR, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

Note 1 — Basis of Presentation and New Accounting Pronouncements
 
Basis of Presentation
The accompanying condensed consolidated financial information included hereinof FormFactor, Inc. is unaudited and has been prepared by FormFactor, Inc. without audit, in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”).Commission. However, such information reflects all adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods. The financial information as of December 30, 201729, 2018 is derived from our 20172018 Annual Report on Form 10-K. The condensed consolidated financial statements included herein should be read in conjunction with the consolidated financial statements and the notes thereto included in our 20172018 Annual Report on Form 10-K. The results of operations for the interim periods presented are not necessarily indicative of the results to be expected for the full year.
 
Fiscal Year 
We operate on a 52/53 week fiscal year, whereby the fiscal year ends on the last Saturday of December. Fiscal 20182019 and 20172018 each contain 52 weeks and the three months ended March 30, 2019 and March 31, 2018 and April 1, 2017 each contained 13 weeks. Fiscal 20182019 will end on December 29, 2018.28, 2019.

Reclassifications
Certain immaterial reclassifications were made to the prior period financial statements to conform to the current period presentation.

Critical Accounting Policies
Our critical accounting policies have not changed during the three months ended March 31, 201830, 2019 from those disclosed in our Annual Report on Form 10-K for the year ended December 30, 2017, except for:

Revenue Recognition

Revenue is recognized upon transferring control of products and services, and the amounts recognized reflect the consideration we expect to be entitled to receive in exchange for these products and services. Revenue is recognized net of any taxes collected from customers, which are subsequently remitted to governmental authorities. An arrangement may include some or all of the following products and services: probe cards, systems, accessories, installation services, service contracts and extended warranty contracts. We sell our products and services direct to customers and to partners in two distribution channels: global direct sales force and through a combination of manufacturers’ representatives and distributors.

A performance obligation is a promise in a contract to transfer a distinct good or service to the customer. In contracts with multiple performance obligations, we identify each performance obligation and evaluate whether the performance obligation is distinct within the context of the contract at contract inception. Performance obligations that are not distinct at contract inception are combined and accounted for as one unit of account. Generally, the performance obligations in a contract are considered distinct within the context of the contract and are accounted for as separate units of account.

Our products may be customized to our customers’ specifications, however, control of our products are typically transferred to the customer at the point in time the product is either shipped or delivered, depending on the terms of the arrangement, as the criteria for overtime recognition are not met. In limited circumstances, substantive acceptance by the customer exists which results in the deferral of revenue until acceptance is formally received from the customer. Judgment may be required in determining if the acceptance clause is substantive.

Installation services are routinely provided to customers purchasing our systems. Installation services are a distinct performance obligation apart from the systems and recognized in the period they are performed. Service contracts, which include repair and maintenance service contracts, and extended warranty contracts are also distinct performance obligations and recognized as our performance obligations are satisfied. This is typically the contractual service period, which ranges from one to two years. For these service contracts recognized over time, we use an input measure, days elapsed, to measure progress.

A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. In determining the transaction price, we evaluate whether the price is subject to refund or adjustment to determine the net consideration to which we expect to be entitled. We generally do not grant return privileges, except


for defective products during the warranty period. Sales incentives and other programs that we may make available to these customers are considered to be a form of variable consideration, which is estimated in determining the contract’s transaction price to be allocated to the performance obligations. We have elected the practical expedient under ASC 606-10-32-18 to not assess whether a contract has a significant financing component as our standard payment terms are less than one year.

For contracts with multiple performance obligations, we allocate the contract’s transaction price to each performance obligation based on its relative standalone selling price. The stand-alone selling prices are determined based on the prices at which we separately sell these products. For items that are not sold separately, we estimate the stand-alone selling prices using our best estimate of selling price.

Transaction price allocated to the remaining performance obligations: On March 31, 2018, we had $3.6 million of remaining performance obligations, which were comprised of deferred service contracts and extended warranty contracts not yet delivered. We expect to recognize approximately 20.6% of our remaining performance obligations as revenue in fiscal 2019, and additional 8.7% in fiscal 2020 and thereafter. The foregoing excludes the value of other remaining performance obligations as they have original durations of one year or less, and also excludes information about variable consideration allocated entirely to a wholly unsatisfied performance obligation.

Contract balances: The timing of revenue recognition may differ from the timing of invoicing to customers. Accounts receivable is recorded at the invoiced amount, net of an allowance for doubtful accounts. A receivable is recognized in the period we deliver goods or provide services or when our right to consideration is unconditional. A contract asset is recorded when we have performed under the contract but our right to consideration is conditional on something other than the passage of time. Contract assets as of March 31, 2018 and December 30, 2017 were $1.5 million and $1.6 million, respectively, and are reported on the Condensed Consolidated Balance Sheet as a component of Prepaid expenses and other current assets.

Contract liabilities include payments received in advance of performance under a contract and are satisfied as the associated revenue is recognized. Contract liabilities are reported on the Condensed Consolidated Balance Sheets on a contract-by-contract basis at the end of each reporting period as a component of Deferred revenue and Deferred rent and other liabilities. Contract liabilities as of March 31, 2018 and December 30, 2017 were $5.2 million and $5.7 million, respectively. During the period ended March 31, 2018, we recognized $2.4 million of revenue that was included in contract liabilities as of December 30, 2017.

Costs to obtain a contract: We generally expense sales commissions when incurred as a component of Selling, general and administrative expense as the amortization period is typically less than one year.

Revenue by Category: Refer to Note 12 of Notes to Consolidated Financial Statements for further details.29, 2018.

New Accounting Pronouncements

ASU 2016-10, ASU 2015-14 and ASU 2014-092018-15
In May 2014,August 2018, the Financial Accounting Standard Board ("FASB") issued Accounting Standards Update ("ASU") No. 2014-09,2018-15, "Revenue from Contracts with Customers,Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract." and, in August 2015, the FASB issued ASU 2015-14, “Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date,” which defers the effective date of ASU 2014-09 by one year. ASU 2014-09 requires an entity to recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which an entity expects to be entitled in exchange for those goods or services. The new guidance also requires expanded disclosures relating to the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. Additionally, qualitative and quantitative disclosures are required about customer contracts, significant judgments and changes in judgments, and assets recognized from the costs to obtain or fulfill a contract. The standard permits the use of either the retrospective or modified retrospective transition methods. In April 2016, the FASB issued ASU 2016-10, “Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing” which was issued to clarify ASC Topic 606, “Revenue from Contracts with Customers” related to (i) identifying performance obligations; and (ii) the licensing implementation guidance. We adopted Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers and all related amendments (collectively “ASC 606”), on December 31, 2017, the first day of fiscal 2018, using the modified retrospective method. We applied ASC 606 to all contracts not completed as of the date of adoption in order to determine any adjustment to the opening balance of retained earnings. Under the modified retrospective adoption method, the comparative financial information has not been restated and continues to be reported underclarifies the accounting standardsfor implementation costs in effect for those periods, ASC 605, "Revenue Recognition", which is also referred to herein as "legacy GAAP."

The adoption of ASC 606 did not have a material impact on our consolidated financial statements as of December 31, 2017. No adjustment was recorded to accumulated deficit as of the adoption date and reported revenue would not have been different under


legacy GAAP. Additionally, we do not expect the adoption of the revenue standard to have a material impact to our net income on an ongoing basis.

cloud computing arrangements. ASU 2017-12
In August 2017, the FASB issued ASU2017-12, "Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities," which changes the recognition and presentation requirements of hedge accounting, including eliminating the requirement to separately measure and report hedge ineffectiveness and changing the presentation to include all items that affect earnings in the same income statement line item as the hedged item. ASU 2017-12 also provides new alternatives for applying hedge accounting to additional hedging strategies, measuring the hedged item in fair value hedges of interest rate risk, reducing the cost and complexity of applying hedge accounting and reducing the risk of material error correction if a company applies the shortcut method inappropriately. ASU 2017-122018-15 is effective for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2018,2019. Early adoption is permitted. ASU 2018-15 should be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. We have not yet determined the impact of this standard on a prospective basis. We early adopted ASU 2017-12 on December 31, 2017, the first day of fiscal 2018, resulting in an immaterial adjustment in our accumulated deficit on December 30, 2017. The adjustment was reflected in our Condensed Consolidated Balance Sheets as of that date.financial statements.

ASU 2017-092016-02, ASU 2018-10, ASU 2018-11 and ASU 2019-01
In May 2017, the FASB issued ASU 2017-09, "Compensation - Stock Compensation (Topic 718) - Scope of Modification Accounting," which provides clarity and reduces both diversity in practice and the cost and complexity when accounting for a change to the terms of a stock-based award. ASU 2017-09 is effective for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2017, on a prospective basis. We adopted ASU 2017-09 on December 31, 2017, the first day of fiscal 2018. There were no modifications to any stock-based awards during the three months ended March 31, 2018.

ASU 2017-04
In January 2017, the FASB issued ASU 2017-04, "Intangibles - Goodwill and Other (Topic 350) - Simplifying the Test for Goodwill Impairment," which simplifies the subsequent measurement of goodwill by eliminating Step 2 from the goodwill impairment test. An entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount, and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit's fair value, if applicable. The loss recognized should not exceed the total amount of goodwill allocated to the reporting unit. The same impairment test also applies to any reporting unit with a zero or negative carrying amount. An entity still has the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. ASU 2017-04 is effective for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2019, on a prospective basis. Early adoption is permitted for interim or annual goodwill impairment tests performed after January 1, 2017. We do not expect the adoption of ASU 2017-04 to have a material effect on our financial position, results of operations or cash flows.

ASU 2016-18
In November 2016, the FASB issued ASU 2016-18, "Statement of Cash Flows (Topic 230) - Restricted Cash," which requires that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. Therefore, an entity should include amounts generally described as restricted cash or restricted cash equivalents within cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. Prior to this ASU, there was no guidance to address how to classify and present changes in restricted cash or restricted cash equivalents. The updated guidance is effective for interim and annual periods beginning after December 15, 2017. We adopted ASU 2016-18 as of December 31, 2017, the first day of fiscal 2018 and retrospectively applied such guidance to our Consolidated Statements of Cash Flows.

The following table provides a reconciliation of Cash and cash equivalents as previously reported within the Condensed Consolidated Statements of Cash Flows to Cash, cash equivalents and restricted cash as currently reported in the Condensed Consolidated Statements of Cash Flows (in thousands):

December 30, 2017 April 1, 2017 December 31, 2016
Cash, cash equivalents as previously reported in the Condensed Consolidated Statements of Cash Flows$91,184
 $114,437
 $101,408
Current assets - Restricted cash372
 4
 106
Restricted cash1,170
 1,116
 1,082
Cash, cash equivalents and restricted cash as currently reported in the Condensed Consolidated Statements of Cash Flows$92,726
 $115,557
 $102,596



As of March 31, 2018, Restricted cash was comprised primarily of funds held by our foreign subsidiaries for employee obligations, office leases and customer deposits.

ASU 2016-02
In February 2016, the FASB issued ASU 2016-02, "Leases,"Leases (Topic 842)," which requires the recognition of right-of-use assets and lease liabilities for all long-term leases, including operating leases, on the balance sheet. The new standard alsoASU 2016-02 was amended in July 2018 by both ASU 2018-10, "Codification Improvements to Topic 842, Leases," and ASU 2018-11, "Leases (Topic 842): Targeted Improvements" and in March 2019 by ASU 2019-01, "Leases (Topic 842): Codification Improvements." ASU 2016-02 provides additional guidance on the measurement of the right-of-use assets and lease liabilities and will requirerequires enhanced disclosures about the Company’sour leasing arrangements. Under current accounting standards, substantially all of the Company’s leases are considered operating leases and, as such, are not recognized on the Consolidated Balance Sheet. This new standard is effective for the Company beginning on January 1, 2019, with early adoption permitted. As initially issued, the standard required a “modified retrospective” adoption, meaning the standard is applied to leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. In March 2019, the FASB approved an amendment toWe adopted Topic 842 thatand all related amendments on December 30, 2018, the first day of fiscal 2019, using the modified transition approach. The modified transition approach permits a company to use its effective date as the date of initial application to apply the standard to its leases, and, therefore, not restate comparative prior period financial information. The CompanyConsequently, prior period financial information is currently assessingnot updated, and the impact ofdisclosures required under the new standard will not be provided for dates and periods before December 30, 2018. The standard provides several optional practical expedients in transition. We elected the ‘package of practical expedients,’ which permits us to not reassess, under the new standard, our prior conclusions about lease identification, lease classification and initial direct costs. We did not elect the use-of-hindsight or the practical expedient pertaining to land easements; the latter not being applicable to us. The new standard also provides practical expedients for an entity’s ongoing accounting. We elected the short-term lease recognition exemption. This means, for those leases that qualify, we will not recognize a right-of-use asset or lease liability, and this includes not recognizing right-of-use assets or lease liabilities for existing short-term leases of those assets in transition. We also elected the practical expedient to not separate lease and non-lease components for all our leases. The adoption of the lease standard did not have any effect on its our previously reported Condensed


Consolidated Financial Statements of Operations and hasdid not yet determined its transition method.result in a cumulative catch-up adjustment to opening equity. See Note 12 for additional information.

Note 2 — Concentration of Credit and Other Risks

Each of the following customers accounted for 10% or more of our revenues for the periods indicated:
 Three Months Ended
 March 31, 2018 April 1, 2017
Intel14.0% 26.7%
SK Hynix10.1
 
Samsung
 10.3
Total revenues attributable to 10% or greater customers24.1% 37.0%
 Three Months Ended
 March 30, 2019 March 31, 2018
Intel Corporation21.3% 14.0%
SK Hynix Inc.*
 10.1
Samsung Electronics., LTD.13.8
 *

35.1% 24.1%
*Represents less than 10% of total revenues.

At March 31, 2018, three30, 2019, two customers accounted for 13.7%, 12.7%16.7% and 10.4%10.7% of gross accounts receivable, respectively. At December 30, 2017,29, 2018, two customers accounted for 24.1%27.8% and 13.6%13.0% of gross accounts receivable, respectively. No other customers accounted for 10% or more of gross accounts receivable at either of these fiscal period ends.

Note 3 — Inventories, net

Inventories are stated at the lower of cost (principally standard cost, which approximates actual cost on a first in, first out basis) or net realizable value.
 
Inventories, net, consisted of the following (in thousands):
March 31,
2018
 December 30,
2017
March 30,
2019
 December 29,
2018
Raw materials$37,156
 $33,101
$44,627
 $43,380
Work-in-progress21,719
 20,134
22,356
 20,431
Finished goods14,905
 14,613
16,233
 13,895
$73,780
 $67,848
$83,216
 $77,706



Note 4 — Goodwill and Intangible Assets

Goodwill by reportable segment was as follows (in thousands):
 Probe Cards Systems TotalProbe Cards Systems Total
Goodwill, gross, as of December 31, 2016 $172,482
 $15,528
 $188,010
Foreign currency translation 
 1,910
 1,910
Goodwill, gross, as of December 30, 2017 172,482
 17,438
 189,920
$172,482
 $17,438
 $189,920
Foreign currency translation 
 447
 447

 (706) (706)
Goodwill, gross, as of March 31, 2018 $172,482
 $17,885
 $190,367
Goodwill, gross, as of December 29, 2018172,482
 16,732
 189,214
Foreign currency translation
 (289) (289)
Goodwill, gross, as of March 30, 2019$172,482
 $16,443
 $188,925

We have not recorded any goodwill impairments as of March 31, 2018.30, 2019.



Intangible assets were as follows (in thousands):
 March 31, 2018 December 30, 2017 March 30, 2019 December 29, 2018
Other Intangible Assets Gross Accumulated Amortization Net Gross Accumulated Amortization Net Gross Accumulated Amortization Net Gross Accumulated Amortization Net
Existing developed technologies
 $144,319
 $82,091
 $62,228
 $143,966
 $76,826
 $67,140
 $143,179
 $101,708
 $41,471
 $143,408
 $97,111
 $46,297
Trade name 12,126
 6,430
 5,696
 12,086
 5,735
 6,351
 11,997
 10,206
 1,791
 12,023
 9,173
 2,850
Customer relationships 40,419
 17,694
 22,725
 40,313
 16,320
 23,993
 40,077
 22,954
 17,123
 40,146
 21,653
 18,493
Backlog 
 
 
 15,811
 15,811
 

 $196,864
 $106,215
 $90,649
 $212,176
 $114,692
 $97,484
 $195,253
 $134,868
 $60,385
 $195,577
 $127,937
 $67,640

Amortization expense was included in our Condensed Consolidated Statements of Income as follows (in thousands):
Three Months EndedThree Months Ended
March 31,
2018
 April 1,
2017
March 30,
2019
 March 31,
2018
Cost of revenues$5,157
 $6,324
$4,719
 $5,157
Selling, general and administrative2,037
 2,025
2,371
 2,037
$7,194
 $8,349
$7,090
 $7,194

The estimated future amortization of intangible assets is as follows (in thousands):
Fiscal Year AmountAmount
Remainder of 2018 $21,590
2019 26,122
Remainder of 2019$19,249
2020 24,052
23,318
2021 13,212
12,592
2022 3,602
3,484
Thereafter 2,071
20231,742
 $90,649
$60,385



Note 5 — Accrued Liabilities

Accrued liabilities consisted of the following (in thousands):
March 31, 2018 December 30, 2017March 30, 2019 December 29, 2018
Accrued compensation and benefits$11,344
 $18,141
$13,135
 $15,600
Accrued employee stock purchase plan contributions withheld1,475
 3,174
Accrued warranty2,839
 3,662
2,021
 2,102
Accrued withholding for employee stock purchase plan1,298
 3,279
Accrued income and other taxes1,877
 3,965
2,906
 4,222
Other accrued expenses6,138
 4,647
3,022
 2,633
$23,496
 $33,694
$22,559
 $27,731



Note 6 — Restructuring Charges
 
Restructuring charges are comprisedin the first quarter of fiscal 2019 compromised of costs related to employee termination benefits, cost of long-lived asset abandonment, as well as contract termination costs, and are included in Restructuring and impairment charges, net in the Consolidated Statements of Income.inventory write downs.

Restructuring charges were $0.3 millionincluded in the first quarterour Consolidated Statement of fiscal 2017 and related to the consolidation of an acquired subsidiary into our operations.Operations as follows (in thousands):
 Three Months Ended
 March 30, 2019 March 31, 2018
Cost of revenues$120
 $
Selling, general, and administrative89
 
 $209
 $

There were no restructuring charges in the first quarter of fiscal 2018. Changes to the restructuring accrual in the three months ended March 31, 201830, 2019 were as follows (in thousands):
 Employee Severance and Benefits Contract Termination and Other Costs Total
Accrual at December 30, 2017$398
 $1
 $399
Cash payments(398) (1) (399)
Accrual at March 31, 2018$
 $
 $
 Employee Severance and Benefits Other Costs Total Accrual
December 29, 2018$20
 $
 $20
Restructuring charges75
 134
 209
Non-cash settlement
 (134) (134)
March 30, 2019$95
 $
 $95

Note 7 — Fair Value and Derivative Instruments

Whenever possible, the fair values of our financial assets and liabilities are determined using quoted market prices of identical securities or quoted market prices of similar securities from active markets. The three levels of inputs that may be used to measure fair value are as follows:
Level 1 valuations are obtained from real-time quotes for transactions in active exchange markets involving identical securities;
Level 2 valuations utilize significant observable inputs, such as quoted prices for similar assets or liabilities, quoted prices near the reporting date in markets that are less active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and
Level 3 valuations utilize unobservable inputs to the valuation methodology and include our own data about assumptions market participants would use in ricingpricing the asset or liability based on the best information available under the circumstances.

We did not have any transfers of assets or liabilities measured at fair value on a recurring basis to or from Level 1, Level 2 or Level 3 during the three months ended March 31, 201830, 2019 or the year ended December 30, 2017.29, 2018.

The carrying values of Cash, Accounts receivable, net, Restricted cash, Prepaid expenses and other current assets, Accounts payable and Accrued liabilities approximate fair value due to their short maturities.

No changes were made to our valuation techniques during the first three months of fiscal 2018.




2019.



Assets and Liabilities Measured at Fair Value on a Recurring Basis
Assets and liabilities measured at fair value on a recurring basis were as follows (in thousands): 
March 31, 2018 Level 1 Level 2 Total
March 30, 2019 Level 1 Level 2 Total
Assets:            
Cash equivalents:            
Money market funds $2,422
 $
 $2,422
 $3,077
 $
 $3,077
Marketable securities:       
 
 
U.S. Treasuries 4,473
 
 4,473
 15,450
 
 15,450
Certificates of deposit 
 955
 955
 
 959
 959
Agency securities 
 9,901
 9,901
 
 11,631
 11,631
Corporate bonds 
 31,544
 31,544
 
 26,046
 26,046
Commercial paper 
 1,497
 1,497
 
 
 
 4,473
 43,897
 48,370
 15,450
 38,636
 54,086
Interest rate swap derivative contracts 
 1,170
 1,170
 
 427
 427
Total assets $6,895
 $45,067
 $51,962
 $18,527
 $39,063
 $57,590
Liabilities:            
Foreign exchange derivative contracts $
 $(327) $(327) $
 $(377) $(377)

December 30, 2017 Level 1 Level 2 Total
December 29, 2018 Level 1 Level 2 Total
Assets:            
Cash equivalents:            
Money market funds $1,064
 $
 $1,064
 $1,184
 $
 $1,184
Corporate bonds 
 774
 774
 1,064
 774
 1,838
Marketable securities:            
U.S. Treasuries 3,963
 
 3,963
 7,997
 
 7,997
Certificates of deposit 
 957
 957
 
 957
 957
Agency securities 
 10,432
 10,432
 
 8,608
 8,608
Corporate bonds 
 30,636
 30,636
 
 30,674
 30,674
Commercial paper 
 3,000
 3,000
 
 2,295
 2,295
 3,963
 45,025
 48,988
 7,997
 42,534
 50,531
Foreign exchange derivative contracts 
 31
 31
Interest rate swap derivative contracts 
 1,043
 1,043
 
 871
 871
Total $5,027
 $46,873
 $51,900
Total assets $9,181
 $43,405
 $52,586
 

We did not have any liabilities measured at fair value on a recurring basis at December 30, 2017.29, 2018.

Cash Equivalents
The fair value of our cash equivalents is determined based on quoted market prices for similar or identical securities.

Marketable Securities
We classify our marketable securities as available-for-sale and value them utilizing a market approach. Our investments are priced by pricing vendors who provide observable inputs for their pricing without applying significant judgment. Broker pricing is used mainly when a quoted price is not available, the investment is not priced by our pricing vendors or when a broker price is more reflective of fair value. Our broker-priced investments are categorized as Level 2 investments because fair value is based on similar assets without applying significant judgments. In addition, all of our investments have a sufficient level of trading volume to demonstrate that the fair value is appropriate.

Unrealized gains and losses were immaterial and were recorded as a component of Accumulated other comprehensive income in


our Condensed Consolidated Balance Sheets. We did not have any other-than-temporary unrealized gains or losses at either period end included in these financial statements.



Interest Rate Swaps
The fair value of our interest rate swap contracts is determined at the end of each reporting period based on valuation models that use interest rate yield curves as inputs. For accounting purposes, our interest rate swap contracts qualify for, and are designated as, cash flow hedges. The cash flows associated with the interest rate swaps are reported in Net cash provided by operating activities in our Condensed Consolidated Statements of Cash Flows and the fair value of the interest rate swap contracts inare recorded within Prepaid expenses and other current assets and Other assets in our Condensed Consolidated Balance Sheets.

The impact of the interest rate swaps on our Condensed Consolidated Statements of Income was as follows (in thousands):

 Amount of Gain or (Loss) Recognized in OCI on Derivative Location of Gain or (Loss) Reclassified from Accumulated OCI into Income Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income Amount of Gain or (Loss) Recognized in Accumulated OCI on Derivative Location of Gain or (Loss) Reclassified from Accumulated OCI into Income Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income Location of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion) Amount of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion )
Three Months Ended March 30, 2019 $(28) Interest expense $(208) Interest expense $
Three Months Ended March 31, 2018 $255
 Interest expense $132
 $255
 Interest expense $132
 Interest expense $
Three Months Ended April 1, 2017 $120
 Interest expense $(37)

Foreign Exchange Derivative Contracts
We operate and sell our products in various global markets. As a result, we are exposed to changes in foreign currency exchange rates. We utilize foreign currency forward contracts to hedge against future movements in foreign exchange rates that affect certain existing foreign currency denominated assets and liabilities and forecasted foreign currency revenue and expense transactions. Under this program, our strategy is to have increases or decreases in our foreign currency exposures mitigated by gains or losses on the foreign currency forward contracts in order to mitigate the risks and volatility associated with foreign currency transaction gains or losses.

We do not use derivative financial instruments for speculative or trading purposes. For accounting purposes, certain of our foreign currency forward contracts are not designated as hedging instruments and, accordingly, we record the fair value of these contracts as of the end of our reporting period in our Condensed Consolidated Balance Sheets with changes in fair value recorded within Other expense,income (expense), net in our Condensed Consolidated Statement of Income for both realized and unrealized gains and losses. Certain of our foreign currency forward contracts are designated as cash flow hedges, and, accordingly, we record the fair value of these contracts as of the end of our reporting period in our Condensed Consolidated Balance Sheets with changes in fair value recorded as a component of accumulated other comprehensive income and reclassified into earnings in the same period in which the hedged transaction affects earnings, and in the same line item on the Condensed Consolidated Statements of Income as the impact of the hedge transaction. At March 30, 2019, we expect to reclassify $0.4 million of the amount accumulated in other comprehensive income (loss) to earnings during the next 12 months, due to the recognition in earnings of the hedged forecasted transactions.

The fair value of our foreign exchange derivative contracts was determined based on current foreign currency exchange rates and forward points. All of our foreign exchange derivative contracts outstanding at March 31, 201830, 2019 will mature in the secondfourth quarter of fiscal 2018.2019.

The following table provides information about our foreign currency forward contracts outstanding as of March 31, 201830, 2019 (in thousands):
Currency Contract Position Contract Amount (Local Currency) Contract Amount (U.S. Dollars) Contract Position Contract Amount (Local Currency) Contract Amount (U.S. Dollars)
Euro Dollar Buy (2,511) $(3,320)
Japanese Yen Sell 983,753
 $9,268
 Buy (324,310) (2,932)
Taiwan Dollar Buy (11,683) (404)
Korean Won Buy (1,871,575) (1,772) Buy (2,982,606) (2,651)
Euro Dollar Sell 16,187
 19,621
Total USD notional amount of outstanding foreign exchange contractsTotal USD notional amount of outstanding foreign exchange contracts $26,713
   $(8,903)

Our foreign currency contracts are classified within Level 2 of the fair value hierarchy as they are valued using pricing models that utilize observable market inputs.



The location and amountimpact of net loss related to non-designatedforeign exchange derivative instruments in thecontracts not designated as cash flow hedges on our Condensed Consolidated Statements of Income werewas as follows (in thousands):
   Amount of Gain Recognized on Derivatives
    Three Months Ended
Derivatives Not Designated as Hedging Instruments Location of Gain Recognized on Derivatives March 30, 2019 March 31, 2018
Foreign exchange forward contracts Other expense, net $314
 $862


The impact of foreign exchange derivative contracts designated as cash flow hedges on our Condensed Consolidated Statements of Income was as follows (in thousands):
    Three Months Ended
Derivatives Not Designated as Hedging Instruments Location of Loss Recognized on Derivatives March 31, 2018 April 1, 2017
Foreign exchange forward contracts Other expense, net $862
 $886
  Amount of Loss Recognized in Accumulated OCI on Derivative Location of Loss Reclassified from Accumulated OCI into Income Amount of Loss Reclassified from Accumulated OCI into Income
Three Months Ended March 30, 2019 $(435) Cost of revenues $(32)
    Research and development (19)
    Selling, general and administrative (7)
      $(58)
       
Three Months Ended March 31, 2018 $
 
 $

Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis
We measure and report goodwill and intangible assets at fair value on a non-recurring basis if we determine these assets to be impaired or in the period when we make a business acquisition. There were no assets or liabilities measured at fair value on a nonrecurring basis during the three months ended March 30, 2019 or March 31, 2018 or April 1, 2017.2018.

Note 8 — Warranty
 
We offer warranties on certain products and record a liability for the estimated future costs associated with warranty claims at the time revenue is recognized. The warranty liability is based upon historical experience and our estimate of the level of future costs. While we engage in product quality programs and processes, our warranty obligation is affected by product failure rates, material usage and service delivery costs incurred in correcting a product failure.costs. We continuously monitor product returns for warranty and maintain a reserve for the related expenses based upon our historical experience and any specifically identified field failures. As we sell new products to our customers, we must exercise considerable judgment in estimating the expected failure rates. This estimating process is based on historical experience of similar products, as well as various other assumptions that we believe to be reasonable under the circumstances.

We provide for the estimated cost of product warranties at the time revenue is recognized as a component of Cost of revenues in our Condensed Consolidated Statement of Income.

A reconciliation of the changesChanges in our warranty liability waswere as follows (in thousands):
Three Months EndedThree Months Ended
March 31,
2018
 April 1,
2017
March 30,
2019
 March 31,
2018
Balance at beginning of period$3,662
 $2,972
$2,102
 $3,662
Accruals1,025
 1,127
889
 1,025
Settlements(1,848) (1,517)(970) (1,848)
Balance at end of period$2,839
 $2,582
$2,021
 $2,839



Note 9 — Stockholders’ Equity and Stock-Based Compensation
 
Common Stock Repurchase Program
In February 2017, our Board of Directors authorized a program to repurchase up to $25 million of outstanding common stock to offset potential dilution from issuances of common stock under our employee stock purchase plan and equity incentive plan. The share repurchase program will expire on February 1, 2020. Repurchased shares are retired upon the settlement of the related transactions with the excess of cost over par value charged to additional paid-in capital. All repurchases are made in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended.

During the three months ended March 31, 2018,30, 2019, we did not repurchase any shares. As of March 31, 2018,30, 2019, $6.0 million remained available for future repurchases.



Restricted Stock Units
Restricted stock unit ("RSU") activity under our equity incentive plan was as follows:
 
 Units Weighted Average Grant Date Fair Value
RSUs at December 30, 20173,148,061
 $11.22
Awards granted46,500
 14.95
Awards vested(59,246) 6.73
Awards forfeited(258,599) 11.60
RSUs at March 31, 20182,876,716
 $11.34
 Units Weighted Average Grant Date Fair Value
RSUs at December 29, 20183,102,226
 $12.79
Awards vested(47,696) 10.17
Awards forfeited(17,501) 12.77
RSUs at March 30, 20193,037,029
 12.83

The total fair value of RSUs vested during the three months ended March 31, 201830, 2019 was $0.9$0.7 million.

Performance Restricted Stock Units
We may grant Performance RSUs ("PRSUs") to certain executives, which vest based upon us achieving certain market performance criteria. There were no PRSUs granted during the three months ended March 31, 2018.first quarter of fiscal 2019. PRSUs are included as part of the RSU activity above.

Stock Options
Stock option activity under our equity incentive plan was as follows:
  Options Outstanding Weighted Average Exercise Price Weighted Average Remaining Contractual Life in Years Aggregate Intrinsic Value
Outstanding at December 30, 2017 659,334
 $8.12
    
Options exercised (105,610) 9.93
    
Outstanding at March 31, 2018 553,724 $7.77
 4.06 $3,253,558
Exercisable at March 31, 2018 429,270
 $7.66
 4.04 $2,572,312

 Options Outstanding Weighted Average Exercise Price Weighted Average Remaining Contractual Life in Years Aggregate Intrinsic Value
Outstanding at December 29, 2018524,725
 $8.00
    
Options exercised(19,207) 4.69
    
Outstanding at March 30, 2019505,518 $8.12
 2.88 $4,028,192
Vested and expected to vest at March 30, 2019505,518
 $8.12
 2.88 $4,028,192
Exercisable at March 30, 2019505,518
 $8.12
 2.88 $4,028,192

Employee Stock Purchase Plan
Information related to activity under our Employee Stock Purchase Plan ("ESPP") was as follows:
 Three Months EndedThree Months Ended
 March 31, 2018March 30, 2019
Shares issued 341,670
301,497
Weighted average per share purchase price $10.84
$12.18
Weighted average per share discount from the fair value of our common stock on the date of issuance $3.51
$4.85



Stock-Based Compensation
Stock-based compensation was included in our Condensed Consolidated Statements of Income as follows (in thousands):
Three Months EndedThree Months Ended
March 31,
2018
 April 1,
2017
March 30,
2019
 March 31,
2018
Cost of revenues$920
 $854
$950
 $920
Research and development1,302
 1,082
1,519
 1,302
Selling, general and administrative1,534
 1,366
2,826
 1,534
Total stock-based compensation$3,756
 $3,302
$5,295
 $3,756
 



Unrecognized Compensation Costs
At March 31, 2018,30, 2019, the unrecognized stock-based compensation was as follows (in(dollars in thousands): 
Unrecognized Expense Average Expected Recognition Period in YearsUnrecognized Expense Average Expected Recognition Period in Years
Stock options$398
 0.90
Restricted stock units21,556
 2.00$20,178
 1.87
Performance restricted stock units4,991
 1.99
Employee stock purchase plan691
 0.30975
 0.84
Total unrecognized stock-based compensation expense$22,645
 1.90$26,144
 

Note 10 — Net Income per Share

The following table reconciles the shares used in calculating basic net income per share and diluted net income per share (in thousands):
Three Months EndedThree Months Ended
March 31,
2018
 April 1,
2017
March 30,
2019
 March 31,
2018
Weighted-average shares used in computing basic net income per share72,826
 71,423
74,362
 72,826
Add potentially dilutive securities1,516
 1,499
1,647
 1,516
Weighted-average shares used in computing diluted net income per share74,342
 72,922
76,009
 74,342
      
Securities not included as they would have been antidilutive19
 126
38
 19

Note 11 — Commitments and Contingencies

Leases
See Note 12.

Contractual Commitments and Purchase Obligations
Our lease commitments, purchase obligations and other contractual obligations have not materially changed as of March 31, 201830, 2019 from those disclosed in our Annual Report on Form 10-K for the year ended December 30, 2017.29, 2018.

Legal Matters
From time to time, we may be subject to legal proceedings and claims in the ordinary course of business. As of March 31, 2018,30, 2019, and as of the filing of this Quarterly Report on Form 10-Q, we were not involved in any material legal proceedings.



Note 12 — Leases

We lease real estate space under non-cancelable operating lease agreements for commercial and industrial space, as well as our corporate headquarters located in Livermore, California. Our leases have remaining terms of 1 to 10 years, and some leases include options to extend up to 20 years. We also have operating leases for automobiles with remaining lease terms of 1 to 4 years. We did not include any of our renewal options in our lease terms for calculating our lease liability as the renewal options allow us to maintain operational flexibility and we are not reasonably certain we will exercise these options at this time. The weighted-average remaining lease term for our operating leases was 8 years at March 30, 2019 and the weighted-average discount rate was 4.7%.

The components of lease expense were as follows (in thousands):
 Three Months Ended
 March 30,
2019
Lease expense:
Operating lease expense$1,745
Short-term lease expense17
Variable lease expense419

$2,181

Future minimum payments under our non-cancelable operating leases were as follows as of March 30, 2019 (in thousands):
Fiscal Year Amount
Remainder of 2019 $4,950
2020 6,698
2021 5,819
2022 4,890
2023 4,432
Thereafter 20,406
  $47,195

Note 1213 — Revenue

Transaction price allocated to the remaining performance obligations: On March 30, 2019, we had $3.9 million of remaining performance obligations, which were comprised of deferred service contracts and extended warranty contracts not yet delivered. We expect to recognize approximately 74% of our remaining performance obligations as revenue in the remainder of fiscal 2019, and approximately 26% in fiscal 2020 and thereafter. The foregoing excludes the value of other remaining performance obligations as they have original durations of one year or less, and also excludes information about variable consideration allocated entirely to a wholly unsatisfied performance obligation.

Contract balances: The timing of revenue recognition may differ from the timing of invoicing to customers. Accounts receivable is recorded at the invoiced amount, net of an allowance for doubtful accounts. A receivable is recognized in the period we deliver goods or provide services or when our right to consideration is unconditional. A contract asset is recorded when we have performed under the contract but our right to consideration is conditional on something other than the passage of time. Contract assets as of March 30, 2019 and December 29, 2018 were $0.6 million and $0.3 million, respectively, and are reported on the Condensed Consolidated Balance Sheets as a component of Prepaid expenses and other current assets.

Contract liabilities include payments received in advance of performance under a contract and are satisfied as the associated revenue is recognized. Contract liabilities are reported on the Condensed Consolidated Balance Sheets on a contract-by-contract basis at the end of each reporting period as a component of Deferred revenue and Other liabilities. Contract liabilities as of March 30, 2019 and December 29, 2018 were $7.6 million and $5.7 million, respectively. During the three months ended March 30, 2019, we recognized $1.4 million of revenue that was included in contract liabilities as of December 29, 2018.

Costs to obtain a contract: We generally expense sales commissions when incurred as a component of Selling, general and administrative expense as the amortization period is typically less than one year.



Revenue by Category: Refer to Note 14 of Notes to Consolidated Financial Statements for further details.

Note 14 — Operating Segments and Enterprise-Wide Information

Our chief operating decision maker ("CODM") is our Chief Executive Officer, who reviews operating results to make decisions about allocating resources and assessing performance for the entire company. We operate in two reportable segments consisting of the Probe Cards Segmentsegment and the Systems Segment.

segment. The following table summarizes the operating results by reportable segment (dollars in thousands):
Three Months EndedThree Months Ended
March 31, 2018 April 1, 2017March 30, 2019 March 31, 2018
Probe Cards Systems Corporate and Other Total Probe Cards Systems Corporate and Other TotalProbe Cards Systems Corporate and Other Total Probe Cards Systems Corporate and Other Total
Revenues$94,928
 $23,362
 $
 $118,290
 $106,496
 $22,333
 $
 $128,829
$108,103
 $24,110
 $
 $132,213
 $94,928
 $23,362
 $
 $118,290
Gross profit$40,071
 $11,135
 $(6,077) $45,129
 $42,820
 $12,090
 $(7,339) $47,571
$45,294
 $13,016
 $(5,789) $52,521
 $40,071
 $11,135
 $(6,077) $45,129
Gross margin42.2% 47.7% % 38.2% 40.2% 54.1% % 36.9%41.9% 54.0% % 39.7% 42.2% 47.7% % 38.2%
Operating income (loss)$18,832

$4,283
 $(19,481) $3,634
 $21,742
 $5,122
 $(19,805) $7,059

Operating results provide useful information to our management for assessment of our performance and results of operations. Certain components of our operating results are utilized to determine executive compensation along with other measures.



Corporate and Other includes unallocated expenses relating to general and administrative costs, amortization of intangible assets, share-based compensation, acquisition-related costs, includingand restructuring charges, related to inventory stepped up to fair value and other costs,net, which are not used in evaluating the results of, or in allocating resources to, our reportable segments. Acquisition-related costs include transaction costs and any costs directly related to the acquisition and integration of acquired businesses.

Certain revenue category information by reportable segment was as follows (in thousands):
Three Months EndedThree Months Ended
March 31, 2018 April 1, 2017March 30, 2019 March 31, 2018
Probe Cards Systems Total Probe Cards Systems TotalProbe Cards Systems Total Probe Cards Systems Total
Type of good/ service:           
Market:           
Foundry & Logic$58,439
 $
 $58,439
 $74,310
 $
 $74,310
$71,580
 $
 $71,580
 $58,439
 $
 $58,439
DRAM30,266
 
 30,266
 28,956
 
 28,956
28,886
 
 28,886
 30,266
 
 30,266
Flash6,223
 
 6,223
 3,230
 
 3,230
7,637
 
 7,637
 6,223
 
 6,223
Systems
 23,362
 23,362
 
 22,333
 22,333

 24,110
 24,110
 
 23,362
 23,362
$94,928
 $23,362
 $118,290
 $106,496
 $22,333
 $128,829
Total$108,103
 $24,110
 $132,213
 $94,928
 $23,362
 $118,290
Timing of revenue recognition:                      
Products transferred at a point in time$94,434
 $22,521
 $116,955
 $106,049
 $21,543
 $127,592
$107,491
 $23,142
 $130,633
 $94,434
 $22,521
 $116,955
Services transferred over time494
 841
 1,335
 447
 790
 1,237
612
 968
 1,580
 494
 841
 1,335
$94,928
 $23,362
 $118,290
 $106,496
 $22,333
 $128,829
Total$108,103
 $24,110
 $132,213
 $94,928
 $23,362
 $118,290
Geographical region:                      
United States$26,557
 $6,375
 $32,932
 $32,687
 $7,154
 $39,841
$27,655
 $6,608
 $34,263
 $26,488
 $6,375
 $32,863
South Korea25,018
 1,705
 26,723
 13,916
 1,074
 14,990
Taiwan25,897
 1,751
 27,648
 18,153
 1,392
 19,545
21,257
 1,130
 22,387
 25,971
 1,751
 27,722
South Korea14,285
 1,074
 15,359
 18,154
 583
 18,737
China18,151
 3,692
 21,843
 9,027
 3,247
 12,274
Japan5,300
 5,132
 10,432
 10,132
 3,540
 13,672
Europe5,373
 4,120
 9,493
 5,573
 5,929
 11,502
Asia-Pacific1
12,154
 4,572
 16,726
 21,371
 4,635
 26,006
2,790
 473
 3,263
 3,490
 1,325
 4,815
Europe5,573
 5,929
 11,502
 4,503
 4,246
 8,749
Japan10,132
 3,540
 13,672
 11,195
 4,038
 15,233
Rest of the world330
 121
 451
 433
 285
 718
2,559
 1,250
 3,809
 331
 121
 452
$94,928
 $23,362
 $118,290
 $106,496
 $22,333
 $128,829
Total$108,103
 $24,110
 $132,213
 $94,928
 $23,362
 $118,290
1 Asia-Pacific includes all countries in the region except Taiwan,China, Japan, South Korea, and Japan,Taiwan, which are disclosed separately.



Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
 
Cautionary Statement Regarding Forward-Looking Statements
 
This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Securities Exchange Act of 1934 and the Securities Act of 1933, which are subject to risks and uncertainties. The forward-looking statements include statements concerning, among other things, our business strategy, financial and operating results, gross margins, liquidity and capital expenditure requirements, impact of accounting standards and our share repurchase plan. In some cases, you can identify these statements by forward-looking words, such as "may," "might," "will," "could," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "intend" and "continue," the negative or plural of these words and other comparable terminology.

The forward-looking statements are only predictions based on our current expectations and our projections about future events. All forward-looking statements included in this Quarterly Report on Form 10-Q are based upon information available to us as of the filing date of this Quarterly Report on Form 10-Q. You should not place undue reliance on these forward-looking statements. We have no obligation to update any of these statements. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by these statements, including risks related to general market trends, our ability to execute our business strategy and other risks discussed in the section titled “Risk Factors” and elsewhere in our Annual Report on Form 10-K for the year ended December 30, 201729, 2018 and in this Quarterly Report on Form 10-Q. You should carefully consider the numerous risks and uncertainties described under these sections.
 
The following discussion and analysis should be read in conjunction with our condensed consolidated financial statements and the accompanying notes contained in this Quarterly Report on Form 10-Q. Unless expressly stated or the context otherwise requires, the terms “we,” “our,” “us” and “FormFactor” refer to FormFactor, Inc. and its subsidiaries.

Overview

FormFactor, Inc., headquartered in Livermore, California, is a leading provider of electrical test and measurement solutions.technologies. We provide a broad range of high-performance probe cards, analytical probes, probe stations and thermal sub-systems to both semiconductor companies and scientific institutions. Our products provide electrical information from a variety of semiconductor and electro-optical devices and integrated circuits (devices) from research, to development tothrough production. Customers use our products and services to lower production costs, improve yields, and enable development of their complex next-generation devices.products.

We operate in two reportable segments consisting of the Probe Cards segment and the Systems segment. Sales of our probe cards and analytical probes are included in the Probe Cards Segment,segment, while sales of our probe stations and thermal sub-systems are included in the Systems Segment.segment.

We generated net income of $5.5 million in the first three months of fiscal 2019 as compared to $2.1 million in the first three months of fiscal 2018 as compared to $5.2 million in the first three months of fiscal 2017.2018. The decreaseincrease in net income was primarily due to decreasedincreased revenue from our Probe Cards segment, and increased operating expenses, partially offset by improved gross margins.higher operating expenses and higher provision for income taxes.

Critical Accounting Policies and the Use of Estimates

Management’s Discussion and Analysis and Note 2 to the Consolidated Financial Statements in our 20172018 Annual Report on Form 10-K describe the significant accounting estimates and critical accounting policies used in preparation of the Consolidated Financial Statements. Actual results in these areas could differ from management’s estimates. During the three months ended March 31, 2018, other than the adoption of new revenue recognition guidance as described in Note 1,30, 2019, there were no significant changes in our critical accounting policies or estimates from those reported in our Annual Report on Form 10-K for the year ended December 30, 2017,29, 2018, which was filed with the Securities and Exchange Commission on February 27, 2018.26, 2019.



Results of Operations
 
The following table sets forth our operating results as a percentage of revenues for the periods indicated:
 
Three Months EndedThree Months Ended
March 31,
2018
 April 1,
2017
March 30,
2019
 March 31,
2018
Revenues100.0 % 100.0 %100.0 % 100.0 %
Cost of revenues61.8
 63.1
60.3
 61.8
Gross profit38.2
 36.9
39.7
 38.2
Operating expenses:      
Research and development15.3
 13.5
14.9
 15.3
Selling, general and administrative19.8
 17.7
19.0
 19.8
Restructuring and impairment charges
 0.2
Total operating expenses35.1
 31.4
33.9
 35.1
Operating income3.1
 5.5
5.8
 3.1
Interest income0.2
 
0.4
 0.2
Interest expense(0.8) (0.9)(0.5) (0.8)
Other expense, net(0.5) (0.3)(0.1) (0.5)
Income before income taxes2.0
 4.3
5.6
 2.0
Provision for income taxes0.2
 0.3
1.5
 0.2
Net income1.8 % 4.0 %4.1 % 1.8 %

Revenues by Segment and Market
Three Months EndedThree Months Ended
March 31, 2018 April 1, 2017March 30, 2019 March 31, 2018
(In thousands)(In thousands)
Probe Cards$94,928
 $106,496
$108,103
 $94,928
Systems23,362
 22,333
24,110
 23,362
$118,290
 $128,829
$132,213
 $118,290

The decrease in Probe Cards Segment revenue for the three months ended March 31, 2018, compared to the three months ended April 1, 2017 was primarily the result of decreased unit sales in the Foundry & Logic market, offset partially by increased unit sales in the DRAM and Flash markets.
 Three Months Ended
 March 30, 2019 % of Revenues March 31, 2018 % of Revenues $ Change % Change
 (Dollars in thousands)
Probe Cards Markets:           
Foundry & Logic$71,580
 54.1% $58,439
 49.4% $13,141
 22.5 %
DRAM28,886
 21.9
 30,266
 25.6
 (1,380) (4.6)
Flash7,637
 5.8
 6,223
 5.3
 1,414
 22.7
Systems Market:

 

 

 

 
 
Systems24,110
 18.2
 23,362
 19.7
 748
 3.2
Total revenues$132,213
 100.0% $118,290
 100.0% $13,923
 11.8 %

The increase in Systems Segment revenue for the three months ended March 31, 2018 compared to the three months ended April 1, 2017 was driven by increased unit sales of thermal sub-systems due to increased customer demand, offset partially by lower revenue from probe stations due to changes in product sales mix which decreased the average selling price of unit sold.

Revenues by Market
 Three Months Ended March 31, 2018 % of Three Months Ended April 1, 2017 % of Change
  Revenues  Revenues $ %
 (In thousands, except percentages)
Probe Cards Markets:           
Foundry & Logic$58,439
 49.4% $74,310
 57.7% $(15,871) (21.4)%
DRAM30,266
 25.6
 28,956
 22.5
 1,310
 4.5
Flash6,223
 5.3
 3,230
 2.5
 2,993
 92.7
Systems Market:           
Systems23,362
 19.7
 22,333
 17.3
 1,029
 4.6
Total revenues$118,290
 100.0% $128,829
 100.0% $(10,539) (8.2)%



The decrease in Foundry & Logic product revenue for the three months ended March 31, 2018,30, 2019, compared to the three months ended April 1, 2017March 31, 2018, was primarily the result of lower demand in the prior year from one major customer.customer as a result of delays in its node transitions. This major customer accounted for 21.3% of total revenues for the first three months ended March 30, 2019, compared to 14.0% for the first three months ended March 31, 2018.

The decrease in DRAM product revenue for the three months ended March 30, 2019, compared to the three months ended March 31, 2018, was driven by decreased unit sales.



The increase in DRAM and Flash product revenue for the three months ended March 31, 2018,30, 2019, compared to the three months ended April 1, 2017March 31, 2018, was thedriven by increased unit sales as a result of increased design wins and customer demand.

The increase in Systems product revenue for the three months ended March 31, 201830, 2019, compared to the three months ended April 1, 2017March 31, 2018, was driven by increased unit sales of thermal sub-systems due to increased customer demand, offset partially by lower revenue from probe stations due to changes in product sales mix of probe stations, which decreased the average selling price of units sold.includes a new 200mm platform, partially offset by lower revenue from thermal sub-systems.

Revenues by Geographic Region
Three Months EndedThree Months Ended
March 31,
2018
 % of
Revenue
 April 1,
2017
 % of
Revenue
March 30, 2019 % of
Revenue
 March 31, 2018 % of
Revenue
(Dollars in thousands)(Dollars in thousands)
United States$32,932
 27.8% $39,841
 30.9%$34,263
 25.9% $32,863
 27.8%
South Korea26,723
 20.2
 14,990
 12.7
Taiwan27,648
 23.4
 19,545
 15.2
22,387
 16.9
 27,722
 23.4
South Korea15,359
 13.0
 18,737
 14.5
Asia-Pacific(1)
16,726
 14.1
 26,006
 20.2
China21,843
 16.5
 12,274
 10.4
Japan10,432
 7.9
 13,672
 11.6
Europe11,502
 9.7
 8,749
 6.8
9,493
 7.2
 11,502
 9.7
Japan13,672
 11.6
 15,233
 11.8
Asia-Pacific1
3,263
 2.5
 4,815
 4.1
Rest of the world451
 0.4
 718
 0.6
3,809
 2.9
 452
 0.4
Total revenues$118,290
 100.0% $128,829
 100.0%$132,213
 100.0% $118,290
 100.0%

(1)1Asia-Pacific includes all countries in the region except Taiwan,China, Japan, South Korea and Japan,Taiwan, which are disclosed separately.
 
Geographic revenue information is based on the location to which we ship the product. For example, if a certain South Korean customer purchases through their U.S. subsidiary and requests the products to be shipped to an address in South Korea, this sale will be reflected in the revenue for South Korea rather than U.S.

Changes in revenue by geographic region for the three months ended March 31, 201830, 2019 compared to the three months ended April 1, 2017March 31, 2018 were primarily attributable to changes in customer demand, shifts in customer regional manufacturing strategies, and product sales mix as previously described.mix.

Cost of Revenues and Gross Margins

Cost of revenues consists primarily of manufacturing materials, payroll,compensation and benefits, shipping and handling costs, manufacturing-related overhead and amortization of certain intangible assets. Our manufacturing operations rely on a limited number of suppliers to provide key components and materials for our products, some of which are a sole source. We order materials and supplies based on backlog and forecasted customer orders. Tooling and setup costs related to changing manufacturing lots at our suppliers are also included in the cost of revenues. We expense all warranty costs, inventory provisions and amortization of certain intangible assets as cost of revenues.

Corporate and Other includes unallocated expenses relating to amortization of intangible assets, share-based compensation expense, acquisition-related costs, including charges related to inventory stepped up to fair value, and other costs, which are not used in evaluating the results of, or in allocating resources to, our reportable segments. Acquisition-related costs include transaction costs and any costs directly related to the acquisition and integration of acquired businesses.

Our gross profit and gross margin were as follows (dollars in thousands):
Three Months EndedThree Months Ended
March 31, 2018 April 1, 2017 $ Change % ChangeMarch 30, 2019 March 31, 2018 $ Change % Change
Gross profit$45,129
 $47,571
 $(2,442) (5.1)%$52,521
 $45,129
 $7,392
 16.4%
Gross margin38.2% 36.9%    39.7% 38.2% 
 



Our gross profit and gross margin by segment were as follows (dollars in thousands):
Three Months EndedThree Months Ended
March 31, 2018 April 1, 2017March 30, 2019 March 31, 2018
Probe Cards Systems Corporate and Other Total Probe Cards Systems Corporate and Other TotalProbe Cards Systems Corporate and Other Total Probe Cards Systems Corporate and Other Total
Gross profit$40,071
 $11,135
 $(6,077) $45,129
 $42,820
 $12,090
 $(7,339) $47,571
$45,294 $13,016
 $(5,789) $52,521
 $40,071 $11,135
 $(6,077) $45,129
Gross margin42.2% 47.7% % 38.2% 40.2% 54.1% % 36.9%41.9% 54.0% % 39.7% 42.2% 47.7% % 38.2%

Probe Cards
For the three months ended March 31, 2018,30, 2019, gross profit in the Probe Cards segment decreasedincreased compared to the three months ended March 31, 2018 primarily due to decreased sales, while grossincreased sales. Gross margins increased due toremained relatively consistent as positive impacts from higher volume and factory utilization were offset by the impact of a less favorable product mix, lower amortization of intangibles and lower inventory reserves, offset partially by decreased factory utilization.mix.

Systems
For the three months ended March 31, 2018,30, 2019, gross profit and gross margin in the Systems segment decreasedincreased compared to the three months ended March 31, 2018 due to changesincreased sales and a favorable product mix.

Corporate and Other includes unallocated expenses relating to amortization of intangible assets, share-based compensation expense, and restructuring charges, net, which are not used in foreign currency exchange rates and changesevaluating the results of, or in product sales mix.allocating resources to, our reportable segments.

Overall
Gross profit and gross margin fluctuate with revenue levels, product mix, selling prices, factory loading and material costs. For the three months ended March 31, 201830, 2019, compared to the three months ended April 1, 2017, gross profit decreased due to lowerMarch 31, 2018, revenue and gross marginsprofit increased due to favorablehigher unit sales and product mix and lower amortization of intangibles.mix.

Cost of revenues included stock-based compensation expense as follows (in thousands):
 Three Months Ended
 March 31,
2018
 April 1,
2017
Stock-based compensation$920
 $854
 Three Months Ended
 March 30,
2019
 March 31,
2018
Stock-based compensation$950
 $920

Future gross margins may be adversely impacted by lower revenues, unfavorable product mix and lower factory utilization even though we have taken significant steps to reduce our operating cost structure. Our gross margins may also be adversely affected if we are required to record additional inventory write-downs for estimated average selling prices of products held in finished goods and work in process inventories that are below the manufacturing cost of those products.cost.

Research and Development
Three Months EndedThree Months Ended
March 31, 2018 April 1, 2017 $ Change % ChangeMarch 30, 2019 March 31, 2018 $ Change % Change
(Dollars in thousands)(Dollars in thousands)
Research and development$18,046
 $17,414
 $632
 3.6%$19,723
 $18,046
 $1,677
 9.3%
% of revenues15.3% 13.5%    14.9% 15.3%    

The increase in research and development expenses in the three months ended March 31, 201830, 2019 when compared to corresponding period in the prior year was primarily due todriven by an increase in project related costs.employee incentive compensation due to increased profitability from higher revenues.



A detail of the changeschange is as follows (in thousands)millions):
 Three Months Ended March 31, 2018 compared to Three Months Ended April 1, 2017
 
Stock-based compensation$220
Project material costs233
Depreciation93
Employee compensation and other general operations86
 $632

 Three Months Ended March 30, 2019 compared to Three Months Ended March 31, 2018
 
Employee compensation costs$1.3
Stock-based compensation0.2
Other general operations0.2

$1.7

Research and development included stock-based compensation expense as follows (in thousands):
 Three Months Ended
 March 31,
2018
 April 1,
2017
Stock-based compensation$1,302
 $1,082
 Three Months Ended
 March 30,
2019
 March 31,
2018
Stock-based compensation$1,519
 $1,302

Selling, General and Administrative
Three Months EndedThree Months Ended
March 31, 2018 April 1, 2017 $ Change % ChangeMarch 30, 2019 March 31, 2018 $ Change % Change
(Dollars in thousands)(Dollars in thousands)
Selling, general and administrative$23,449
 $22,829
 $620
 2.7%$25,184
 $23,449
 $1,735
 7.4%
% of revenues19.8% 17.7%    19.0% 19.8% 
 

The increase in selling, general and administrative in the three months ended March 31, 201830, 2019 when compared to the corresponding period in the prior year was primarily due to an increase in employee incentive compensation due to increased profitability from higher integration costsrevenues and consulting fees,stock-based compensation, partially offset partially by a reduction in travel related costs. consulting fees.
A detail of the changeschange is as follows (in thousands)millions):
 Three Months Ended March 31, 2018 compared to Three Months Ended April 1, 2017
 
Integration related$428
Consulting fees279
Stock-based compensation168
Travel related costs(333)
Employee compensation and other general operating costs63
Depreciation and amortization15
 $620
 Three Months Ended March 30, 2019 compared to Three Months Ended March 31, 2018
 
Consulting fees$(1.0)
Stock-based compensation1.3
Employee compensation1.1
Amortization of intangibles0.3

$1.7

Selling, general and administrative included stock-based compensation expense as follows (in thousands):
 Three Months Ended
 March 31,
2018
 April 1,
2017
Stock-based compensation$1,534
 $1,366

Restructuring Charges, net
 Three Months Ended
 March 31,
2018
 April 1,
2017
Restructuring charges, net$
 $269
% of revenues% 0.2%

Restructuring charges are comprised of costs related to employee termination benefits, cost of long-lived assets abandoned or impaired, as well as contract termination costs.

Restructuring charges in the first quarter of fiscal 2017 were related to the consolidation of Cascade Microtech into our operations.
 Three Months Ended
 March 30,
2019
 March 31,
2018
Stock-based compensation$2,826
 $1,534



Interest Income and Interest Expense
Three Months EndedThree Months Ended
March 31,
2018
 April 1,
2017
March 30,
2019
 March 31,
2018
(Dollars in thousands)(Dollars in thousands)
Interest income$257
 $67
Interest Income$580
 $257
Weighted average balance of cash and investments$133,634
 $111,808
$151,451
 $133,634
Weighted average yield on cash and investments1.50% 0.48%2.03% 1.50%
      
Interest expense$967
 $1,174
Interest Expense$595
 $967
Average debt outstanding$106,058
 $139,224
$64,835
 $106,058
Weighted average interest rate on debt3.61% 2.78%4.51% 3.61%
 
Interest income is earned on our cash, cash equivalents, restricted cash and marketable securities. The increase in interest income for the three months ended March 31, 201830, 2019 compared with corresponding period of the prior year iswas attributable to higher investment yields.yields, as well as higher average investment balances.

Interest expense primarily includes interest on our term loan and interest-rate swap derivative contracts, andas well as term loan issuance costs amortization charges. The decrease in interest expense for the three months ended March 31, 201830, 2019 compared to three months ended April 1, 2017the same period of the prior year was primarily due to a lower outstanding debt balancebalances as a result of principal payments made.made, partially offset by higher interest rates.

Other Income (Expense),Expense, Net
Other income (expense),expense, net, primarily includes the effects of foreign currency impact and various other gains and losses.

Provision for Income Taxes
Three Months EndedThree Months Ended
March 31,
2018
 April 1,
2017
March 30,
2019
 March 31,
2018
(Dollars in thousands)(In thousands, except percentages)
Provision for income taxes287
 367
$2,032
 $287
Effective income tax rate11.9% 6.6%
Effective tax rate27.0% 11.9%

Provision for income taxes reflects the tax provision on our operations in foreign and U.S. jurisdictions, offset by tax benefits from lapsing of statute of limitations related to uncertain tax positions in foreign jurisdictions. We continue to maintain a fullIn the fourth quarter of fiscal 2018 we released our valuation allowance against ourcertain U.S. Federal and State deferred tax assets. The changeassets as sufficient positive evidence existed to support the realization of such deferred tax assets, resulting in provision for taxes primarily relates to higher profits in foreign jurisdictions and an increase in state income taxes dueour effective tax rate for the three months ended March 30, 2019 compared to fully utilized net operating losses in certain state jurisdictions.the three months ended March 31, 2018.


Liquidity and Capital Resources

Capital Resources
Our working capital was $215.2$237.7 million at March 31, 201830, 2019, which did not change significantly with $213.7compared to $235.3 million at December 30, 2017.29, 2018.

Cash and cash equivalents primarily consist of deposits held at banks and money market funds. Marketable securities primarily consist of U.S. agency securities and corporate bonds. We typically invest in highly-rated securities with low probabilities of default. Our investment policy requires investments to be rated single A or better, and limits the types of acceptable investments, issuer concentration and duration of the investment.

Our cash, cash equivalents and marketable securities totaled approximately $142.1$159.8 million at March 31, 2018, as30, 2019, compared to $140.2$149.0 million at December 30, 2017.29, 2018. We believe that we will be able to satisfy our working capital requirements and scheduled term loan repayments for at least the next twelve months with the liquidity provided by our existing cash, cash equivalents, marketable securities and cash provided by operations. To the extent necessary, we may consider entering into short and long-term debt


obligations, raising cash through a stock issuance, or obtaining new financing facilities, which may not be available on terms favorable to us. Our future capital requirements may vary materially from those now planned.



If we are unsuccessful in maintaining or growing our revenues, maintaining or reducing our cost structure (in response to an industry demand downturn or other event), or increasing our available cash through debt or equity financings, our cash, cash equivalents and marketable securities may decline in fiscal 2018.2019.

We utilize a variety of tax planning and financing strategies in an effort to manage our worldwide cash and deploy funds to locations where they are needed. As part of these strategies, we indefinitely reinvest a significant portion of our foreign earnings and our current plans do not demonstrate a need to repatriate these earnings. Should we require additional capital in the United States, we may elect to repatriate indefinitely-reinvested foreign funds or raise capital in the United States.

Cash Flows
The following table sets forth our net cash flows from operating, investing and financing activities:
Three Months EndedThree Months Ended
March 31, 2018 April 1, 2017March 30, 2019 March 31, 2018
(In thousands)(In thousands)
Net Cash provided by operating activities$9,322
 $17,803
Net cash provided by operating activities$20,638
 $9,322
Net cash used in investing activities$(3,391) $(3,451)(9,332) (3,391)
Net cash used in financing activities$(4,353) $(2,651)(3,932) (4,353)

Operating Activities 
Net cash provided by operating activities for the three months ended March 31, 201830, 2019 was primarily attributable to our operations generating $18.3 million of cash (a net income of $2.1$5.5 million which included $16.2and $20.6 million of net non-cash expenses),expenses, offset by operating assets and liabilities using $9.0$5.5 million of cash as discussed in more detail below.

Accounts receivable, net, decreased $3.0$13.8 million to $78.5 million at March 31, 2018 compared to $81.5 million at March 30, 2019, compared to 95.3 million at December 30, 201729, 2018, as a result of decreased revenues,changes in customer sales mix, timing of customer shipments and contractual payment terms.timing of customer payments.

Inventories, net, increased $5.9$5.5 million to $73.8$83.2 million at March 31, 201830, 2019, compared to $67.8$77.7 million at December 30, 201729, 2018, as a result of increased inventory build in anticipationpurchases to shorten lead time and improve pricing, and timing of future revenue growth.customer demand.

Accounts payable increased $3.8decreased $8.5 million to $38.9$31.6 million at March 31, 201830, 2019, compared to $35.0$40.0 million at December 30, 201729, 2018, as a result of timing of vendor payments.

Accrued liabilities decreased $10.2$5.2 million to $23.5$22.6 million at March 31, 201830, 2019, compared to $33.7$27.7 million at December 30, 201729, 2018, as a result of timing of employee payroll, decreases in accruals for employee stock purchase plan salarieswithholdings due to timing within the plan's withholding period, and bonuses.a decrease in accrued sales taxes due to timing of payments.

Investing Activities
Net cash used in investing activities for the three months ended March 31, 201830, 2019 was primarily related to $3.8$6.0 million of cash used in the acquisition of property, plant and equipment, partially offset by $0.4as well as $3.3 million of net maturitiespurchases of marketable securities.

Financing Activities
Net cash used in financing activities for the three months ended March 31, 201830, 2019 primarily related to $8.8$7.5 million of principal payments made towards the repayment of our term loan and $0.4$0.3 million related to tax withholdings associated with the net share settlements of our equity awards, partially offset by $4.8$3.9 million of proceeds received from issuances of common stock under our employee stock purchase plan and exercise of stock options.option plans.



Debt Facility

On June 24, 2016, we entered into a credit agreement (the “Credit Agreement”) with HSBC Bank USA, National Association ("HSBC"). Pursuant to the Credit Agreement, the lenders provided us with a senior secured term loan facility of $150 million (the “Term Loan”). The proceeds of the Term Loan were used to finance a portion of the purchase price paid in connection with the acquisition of Cascade Microtech.

The Term Loan bears interest at a rate equal to, at our option, (i) the applicable London Interbank Offered Rate ("LIBOR") rate plus 2.00% per annum or (ii) Base Rate (as defined in the Credit Agreement) plus 1.00% per annum. We have currently elected to pay interest at 2.00% over the one-month LIBOR rate. Interest payments are payable in quarterlymonthly installments over a five-year period.

On July 25, 2016 we entered into an interest rate swap agreement with HSBC and other lenders to hedge the interest payments on the Term Loan for the notional amount of $95.6 million. As future levels of LIBOR over the life of the loan are uncertain, we entered into these interest-rate swap agreements to hedge the exposure in interest rate risks associated with movement in LIBOR rates. By entering into the agreements, we convert a floating rate interest at one-month LIBOR plus 2% into a fixed rate interest at 2.939%. As of March 30, 2019, the notional amount of the loan that is subject to this interest rate swap is $45.0 million. See Note 7 of Notes to Condensed Consolidated Financial Statements for additional information.

period. The Term Loan amortizes in equal quarterly installments, which began June 30, 2016, in annual amounts equal to 5% for year one, 10% for year two, 20% for year three, 30% for year four and 35% for year five. The Credit Agreement allows voluntary prepayment to be made at any time to prepay the Term Loan in whole or in part without penalty or premium. As of March 30, 2019, we have made prepayments of $40.0 million in addition to scheduled installments per the Credit Agreement. For the three months ended March 30, 2019, we did not make any prepayments in addition to scheduled installments.

The obligations under the Term Loan are guaranteed by substantially all of our assets and the assets of our domestic subsidiaries, subject to certain customary exceptions.

The Credit Agreement contains negative covenants customary for financing of this type, as well as certain financial maintenance covenants. As of March 31, 2018,30, 2019, the balance outstanding pursuant to the term loanTerm Loan was $97.5$57.5 million at an interest rate of 3.65%4.5% and we were in compliance with all covenants under the Credit Agreement.

The Credit Agreement allows voluntary prepayment to be made at any time and from time to time to prepay the Term Loan in whole or in part without penalty or premium. As of March 31, 2018, we have made prepayments of $30.0 million in addition to scheduled installments per the Credit Agreement. For the three months ended March 31, 2018, we made prepayment of $5.0 million in addition to scheduled installment.

Stock Repurchase Program

In February 2017, our Board of Directors authorized a program to repurchase up to $25 million of outstanding common stock to offset potential dilution from issuances of common stock under our stock-based compensation plans. The share repurchase program will expire on February 1, 2020. During the three months ended March 31, 2018,30, 2019, we did not repurchase any shares of common stock. As of March 31, 2018,30, 2019, $6.0 million remained available for future repurchases.

Repurchased shares are retired upon the settlement of the related trade transactions with the excess of cost over par value charged to additional paid-in capital. All repurchases were made in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended.

Contractual Obligations and Commitments

OurOther than our operating lease commitments as disclosed in Note 12 of Notes to Condensed Consolidated Financial Statements, our contractual obligations and commitments have not materially changed as of March 31, 201830, 2019 from those disclosed in our Annual Report on Form 10-K for the year ended December 30, 2017.29, 2018.

Off-Balance Sheet Arrangements
 
Historically, we have not participated in transactions that have generated relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. As of March 31, 2018,30, 2019, we were not involved in any such off-balance sheet arrangements.



Recent Accounting Pronouncements

See Note 1 of Notes to Condensed Consolidated Financial Statements.


Item 3. Quantitative and Qualitative Disclosures about Market Risk
 
For financial market risks related to changes in interest rates and foreign currency exchange rates, reference is made to Item 7A “Quantitative and Qualitative Disclosures about Market Risk” contained in Part II of our Annual Report on Form 10-K for the fiscal year ended December 30, 2017.29, 2018. Our exposure to market risk has not changed materially since December 30, 2017.29, 2018.

Item 4. Controls and Procedures
 
Evaluation of Disclosure Controls and Procedures
 
Based on our management’s evaluation (with the participation of our principal executive officer and principal financial officer), as of the end of the period covered by this report, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, (the “Exchange Act”)) are effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms and is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting
 
BeginningAs of December 31, 2017,30, 2018, we implemented ASC 606, "Revenue from Contracts with Customers", which required the implementation of internal controls to ensure we adequately evaluated our contracts and properly assessedvalued the impact onright-of-use assets and lease liabilities for the new accounting standard. In addition, although the new revenue standard is expectedrelated to have an immaterial impactleases on our ongoing revenuefinancial statements. There have been no other changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that have materially affected, or net income, we implemented changesare likely to materially affect, our policies and internal controls related to revenue recognition.control over financial reporting.

Limitations on the Effectiveness of Controls
 
Control systems, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control systems’ objectives are being met. Further, the design of any control systems must reflect the fact that there are resource constraints, and the benefits of all controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision making can be faulty and that breakdowns can occur because of a simple error or mistake. Control systems can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based, in part, on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

CEO and CFO Certifications
 
We have attached as exhibits to this Quarterly Report on Form 10-Q the certifications of our Chief Executive Officer and Chief Financial Officer, which are required in accordance with the Exchange Act. We recommend that this Item 4 be read in conjunction with the certifications for a more complete understanding of the subject matter presented. 



PART II - OTHER INFORMATION
 
Item 1A. Risk Factors

There have been no material changes during the three months ended March 31, 201830, 2019 to the risk factors discussed in our Annual Report on Form 10-K for the year ended December 30, 2017.29, 2018. If any of the identified risks actually occur, our business, financial condition and results of operations could suffer. The trading price of our common stock could decline and you may lose all or part of your investment in our common stock. The risks and uncertainties described in our Annual Report on Form 10-K for the year ended December 30, 201729, 2018 are not the only ones we face. Additional risks that we currently do not know about or that we currently believe to be immaterial may also impair our business operations.
 
Item 6. Exhibits

The following exhibits are filed herewith and this list constitutes the exhibit index.
ExhibitIncorporated by ReferenceFiled
NumberExhibit DescriptionFormDateNumberHerewith
10.01+X
31.01X
31.02X
32.01*
101.INSXBRL Instance DocumentX
101.SCHXBRL Taxonomy Extension Schema DocumentX
101.CALXBRL Taxonomy Extension Calculation Linkbase DocumentX
101.DEFXBRL Taxonomy Extension Definition Linkbase DocumentX
101.LABXBRL Taxonomy Extension Label Linkbase DocumentX
101.PREXBRL Taxonomy Extension Presentation Linkbase DocumentX
Exhibit   Incorporated by Reference Filed
Number Exhibit Description Form Date Number Herewith
3.1 

 S-1 October 20, 2003 3.01  
3.2 

 8-K July 22, 2016 3.2  
31.01        X
31.02        X
32.01        *
101.INS XBRL Instance Document       X
101.SCH XBRL Taxonomy Extension Schema Document       X
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document       X
101.DEF XBRL Taxonomy Extension Definition Linkbase Document       X
101.LAB XBRL Taxonomy Extension Label Linkbase Document       X
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document       X
           
 ______________________________________
*This exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, whether made before or after the date hereof and irrespective of any general incorporation language in any filings.

+ Indicates a management contract or compensatory plan or arrangement.



SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
  FormFactor, Inc.
    
Date:May 8, 20187, 2019By:/s/ SHAI SHAHAR
    
   Shai Shahar
   Chief Financial Officer
   (Duly Authorized Officer, Principal Financial Officer, and Principal Accounting Officer)


29